FDA Import Refusal 1FX-3577274-7/10002/1 — Novartis Pharmaceuticals Canada Inc.
The FDA refused shipment 1FX-3577274-7/10002/1 from Novartis Pharmaceuticals Canada Inc. (Canada) on Mar 12, 2026. The refused product falls under Drugs and Biologics — CARBAMAZEPINE (ANALGESIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Mar 12, 2026
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 60LCY14 CARBAMAZEPINE (ANALGESIC)
- Charges
- 75